Oxidative stress has been proposed t o be involved in the immunologic defect observed in effector cells of the immune system as well as in lymphocyte cell death and viral replication in human immunodeficiency virus (HIV)-infected patients. Because thiol-containing antioxidants such as Nacetyl-L-cysteine have been shown t o have beneficial effects on CD4+ lymphocyte survival and t o inhibit programmed cell death and HIV-1 replication, they may play a role in therapeutic strategies of this disease. In this work we have studied the cellular thiol levels and the effect of in vitro antioxidant treatment of purified CD4' lymphocytes from HIV-infected patients, and correlated these parameters t o proliferative responses and programmed cell death. We show that CD4' lymphocytes from HIV-infected patients display impaired proliferative responses and a significant decrease in cellular ROGRESSIVE DEPLETION of CD4+ T cells is the P hallmark of human immunodeficiency virus (HIV) infection.' However, in asymptomatic HIV-infected individuals, despite adequate CD4+ T-cell counts, early impairment of immune responses may also occur.'" These functional defects observed in both CD8+ and CD4+ T cells (unresponsiveness to recall antigens or stimulation through the CD3/ TCR complex, and decreased interleukin-2 [IL-21 secretion), exhibit properties reminiscent of an anergic state. ' Oxidative stress has been proposed to play an important role in increased programmed cell death (PCD) and functional impairment of CD4+ lymphocytes currently observed during HIV-1 infection.'.' In this respect, decreased levels of reduced glutathion and enhanced oxidized glutathion in peripheral blood mononuclear cells (PBMC), CD4+, and CD8+ lymphocytes have been reported in these patients."" In addition, N-acetyl-L-cysteine (NAC) has been reported to have beneficial effects on CD4 lymphocyte survival when administrated to HIV-1 -infected individuals," and to inhibit tumor necrosis factor-a (TNF-a)-and phorbol myristate acetate (PMA)-induced cell death in HIV-infected U937 cell lines.I7 Increased oxidative stress has also been shown to activate HIV-1 repli~ation'~.'~ through activation of the NFkB transcription factor. Several antioxidants, including NAC, were described as potent in vitro inhibitors of viral replication in different cellular systems.".'' In the present study we have evaluated the redox status and the effects of in vitro NAC treatment of purified CD4+ lymphocytes from HIV-infected patients and correlated these parameters to proliferative responses and programmed cell death. We have observed that purified CD4+ lymphocytes from HIV-infected showed a significant decrease in basal and postactivation levels of low-molecular-weight thiols and an important impairment in proliferative responses suggesting an in vivo oxidative stress. In vitro preincubation with NAC plus 2-0-mercaptoethanol (2-ME) succeeded to restore proliferative responses and thiol levels in a high proportion of patients (high antioxidant responders [HAR]). In contrast to the HAR, patients failing to respond to antioxidant treatment were characterized by a significant increase in the ratio of apoptotic CD4+ cells that could not be influenced by antioxidants.
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thiol levels, indicating a disturbed redox status. Interestingly, antioxidant treatment succeeded t o restore defective proliferative responses to CD3-mediated activation in 8 of 11 patients (high antioxidant responders). In contrast t o high responders, patients failing t o respond t o antioxidant treatment (low antioxidant responders), were characterized by an abnormal ratio of apoptotic cells, which was not affected by Nacetyl-L-cysteine and/or 2-e-mercaptoethanol preincubation. These results demonstrate for the first time that antioxidant treatment is able t o revert the impaired proliferative activity of CD4 cells from HIV-infected patients and could help designing therapeutic strategies with antioxidant drugs. However, this action is not observed in cells undergoing programmed cell death.
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replication in different cellular systems.".'' In the present study we have evaluated the redox status and the effects of in vitro NAC treatment of purified CD4+ lymphocytes from HIV-infected patients and correlated these parameters to proliferative responses and programmed cell death. We have observed that purified CD4+ lymphocytes from HIV-infected showed a significant decrease in basal and postactivation levels of low-molecular-weight thiols and an important impairment in proliferative responses suggesting an in vivo oxidative stress. In vitro preincubation with NAC plus 2-0-mercaptoethanol (2-ME) succeeded to restore proliferative responses and thiol levels in a high proportion of patients (high antioxidant responders [HAR] ). In contrast to the HAR, patients failing to respond to antioxidant treatment were characterized by a significant increase in the ratio of apoptotic CD4+ cells that could not be influenced by antioxidants.
MATERIALS AND METHODS
Patients and controls. PB samples were obtained from 1 1 asymptomatic HIV-I -infected patients with CD4 counts >300/pL (mean = 395/pL) followed up at the Hospital of the Pasteur Institute. Seropositive status was determined by the presence of serum antibodies to HIV-1 in two separate serum samples as determined by specific enzyme-linked immunosorbent assay (Elavia I; Diagnostics Pasteur, Paris, France) and confirmed by Western blot analysis (Lavblot; Diagnostic Pasteur). Controls were I O sex-and age-matched HIV-I seronegative healthy volunteers.
Anti-CDl6 (3G8,IgGl) and anti-CD56 (T199,IgGl) monoclonal antibodies (MoAbs) used for panning were purchased from Jackson Immunoresearch (Marseille, France). Murine anti-CD19 (HD37,IgGI), anti-CD8 (DK25,IgGl), and anti-CD14 (TUK4JgG2a) MoAbs also used for panning, and anti-CD3 MoAb (UCH-TI ,IgG I ) used for lymphocyte stimulation were purchased from Dako (Dakoppats AS, Denmark).
Purification of CD4 T lymphocytes was proceeded as previously reported.' Briefly, PB lymphocytes (PBL) isolated in a Ficoll gradient, were incubated in the presence of anti-CD8, CD19, CD16, CD56, and CD14 antibodies followed by incubation in the presence of sheep-antimouse-coated immunomagnetic beads (Dynabeads, Dynal, Norway) to achieve a 5:l bead-to-cell ratio. After incubation for 60 minutes at 4°C cell Antibodies.
Isolation of CD4 T lymphocytes.
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For personal use only. on October 22, 2017. by guest www.bloodjournal.org From fractions were separated by the application of a magnet to the outside of the tube for 3 minutes; unbound cells, enriched for CD4 T cells, were carefully aspirated and a second round of immunomagnetic separation was performed for an additional period of 60 minutes at 4°C with a bead-to-cell ratio of 1O:l. Purity of subsets was evaluated at the end of the enrichment procedures. In all experiments, punty of cell preparations was greater than 90% for CD3+CD4+ cells, as determined by immunofluorescence analysis using an EPICS 752 flow cytometer (Coulter, Hialeah, FL).
Addition of NAC (Sigma, St Louis, MO) was made from freshly preparated stock solutions in RPMI-1640 titrated to pH 7.2 with NaOH. For antioxidant treatment, cells were resuspended at 5 X 106/mL in serum-free RPMI-1640 and incubated with NAC (20 mmoUL) and 2-ME (50 pmoUL; Sigma) for 2 hours at 37°C. Cells were then washed twice to remove excess of antioxidants and finally resuspended in 10% fetal calf serum (FCS) RPMI-1640.
For 3H-thymidine uptake, cells were cultivated in 96-well culture plates at 5 X lo4 cells per well in a total volume of 200 pL of supplemented RPMI-1640 culture medium (10% human pooled AB serum [Jacques Boy, Paris, France], glutamine 4 mmol/L, HEPES 20 mmoUL, sodium pyruvate 10 mmoU L, and penicillidstreptomycin). Stimulation was performed by the addition of immunomagnetic beads precoated with saturating doses of mouse-antihuman CD3 IgG MoAb at a bead-to-cell ratio of 5: 1. After 3 days, cultures were pulsed with 1 pCi of [3H]-thymidine (CEA, Paris, France) during the last 18 hours of culture and then procured with a cell harvester system (Tomtec Inc. Orange, CT) and radioactivity was measured in a micro beta plate scintillation counter (LKB). All cultures were performed in quadruplicate, and for each experiment a control using only culture medium was performed.
Flow cytometry analysis was performed on an EPICS 752 fluorescent activated cell sorter (Coulter Corp) as previously reported.6 To standardize the assays and to correct for day-to-day variations in instrument performance, the mean ff uorescence of calibration beads (Standard-Brite; Coulter Corp) was used to adjust reference fluorescence. A total of at least 10, OOO cells were analyzed for each sample and data were stored in a histogram mode.
Intracellular thiol levels were estimated by flow cytometry using the 5-chloromethyl fluorescein diacetate (CMF) probe.19 This nonfluorescent probe has been shown to form fluorescent adducts with intracellular low-molecular thiols, of which GSH is by far the most abundant. Intracellular thiol levels were measured by the method previously described by Poot et ai?' with minor modifications. Briefly, a stock solution of 5-chloromethyl fluorescein diacetate was made up in dimethyl sulfoxide (DMSO) at 5 pmol/L and stored in the dark at -20°C. Cells were resuspended at 106/mL in serum-free medium and equilibrated at 37°C. CMF was added to obtain a final concentration of 50 nmoVL and incubated for 10 minutes in the dark at 37°C. The cells were immediately analyzed in the EPICS 752 flow cytometer.
The fluorescent dye merocyanine 540 (MC 540; Fluka Chemical Corp, Ronkonkona, NY), is a lipid packing probe that binds avidly to the symmetric membranes with exposed phosphatidyl-serine, and has been successfully used as a fluorescent probe in cytometric analysis of apoptotic cells. In recent reports from Fadok et al'' and from our laboratory:' it has been demonstrated that highly fluorescent cells contain more than 90% apoptotic cells. For staining, a stock solution of merocyanine was prepared in 50% ethanol at 1 mg/mL and stored in the dark at -20°C. A working solution was freshly prepared by diluting merocyanine at 11500 (final concentration 2 pg/mL) in a HEPESbuffered salt solution with 0.1% bovine serum albumin (BSA; Antioxidant preincubation of CD4' lymphocytes.
Cell proliferation assays.
Flow cylomerry analysis.
Staining for intracellular low-molecular-weight rhiols.
Flow cytometric analysis of apoptoric cells.
Sigma). Then, lo6 cells were resuspended in 100 pL of working solution and incubated for 5 minutes in the dark at room temperature. Cells were then washed twice with HEPES-buffered salt solution without BSA and immediately analyzed on the EPICS 752 flow cytometer.
The nonparametric two-sided WilcoxonMann-Whitney rank test was used for statistical comparison of [3H]-thymidine uptake or thiol levels between groups. The Spearman rank correlation was used for correlation analysis between thiol levels and thymidine uptake.
Statistical analysis.
RESULTS
Defective proliferative responses of purified CD4 cells from HIV-infected patients. As previously reported, the proliferative responses of CD4 T cells to CD3-mediated from HIV-infected patients were defective and ranged from about 10% to 90% of those observed in normal CD4 T cells (Table   1 , left panel).
Basal intracellular low molecular thiol levels in CD4' lymphocytes from HZV-infected patients. In a first series of experiments we have measured the thiol levels in purified CD4 T cells from 1 1 HIV-infected patients and 6 healthy volunteers. For this, we used the chloromethyl-fluorescein probe, which forms fluorescent adducts with low-molecularweight thiols, including GSH. Levels of cellular thiols were monitored by flow cytometry and values expressed as the mean log of the relative fluorescence intensity. As depicted in Table 2 , resting CD4 T cells from HIV' individuals showed a decrease of about 15% in mean values of log CMF fluorescence with respect to CD4+ lymphocytes from healthy volunteers. As depicted in Table 2 , resting CD4 T cells from HIV+ individuals showed a significant decrease in mean values of log CMF fluorescence with respect to CD4' lymphocytes from healthy volunteers (Wilcoxon-Mann-Whitney rank test P < .05). However, no statistical correlation between LMT levels and proliferative responses in the HIVinfected group was found.
Relationship between cellular thiol levels, response to antioxidant treatment, and proliferative responses in normal donors and asymptomatic HIV-infectedpatients. To further elucidate the relationship between cellular redox status and CD3-mediated proliferative responses, purified CD4' lymphocytes were either untreated or preincubated for 2 hours in the presence of NAC and 2-ME. Then cells were activated with immobilized anti-CD3 MoAbs and thymidine uptake was determined after 4 days of culture. To define optimal experimental conditions and to exclude a potential toxic effect of NAC, isolated normal CD4 cells were incubated with 5, 10, and 20 mmoK concentrations of NAC before any activation of the cell, during activation, or after the activation process with anti-CD3 MoAb. These results are depicted in Fig 1, where it is shown that when activation was carried out in the presence of NAC, there is a dose-dependent inhibition of lymphocyte proliferation, whereas preincubation with NAC followed by washing of supernatants and subsequent stimulation induces opposite results. Furthermore, similar results were reported by Aillet et al. 23 Next we proceeded to preincubate isolated CD4 cells with antioxidants. As shown in Table 2 , preincubation with antioxidants significantly enhanced the proliferative responses of normal CD4 T Values of thymidine uptake are depicted as cpm x and were performed after 72 hours of culture.
cells when compared with untreated cells (1.5-fold increase). Preincubation with either NAC or 2-ME alone increased proliferative responses in a similar ratio for normal CD4 T cells when compared with untreated cells, although the best results were observed with the association of NAC and ME (data not shown). According to thymidine uptake increase in CD4' lymphocytes following antioxidant treatment (Table  I , right panel), HIV-infected patients could be clearly segregated into two groups: "low antioxidant responders" (LAR, 3 of 11) and "high antioxidant responders" (HAR, 8 of 11). In the HAR group, antioxidant treatment significantly enhanced proliferative responses to approach values close to those achieved with normal CD4 T cells after antioxidant treatment. These results indicate that impaired proliferative responses observed in CD4' lymphocytes during asymptomatic HIV-1 infection could be restored in a significant proportion of patients by antioxidants. However, as shown in Table I with NAC t 2-ME contents in resting lymphocytes from both healthy volunteers and HIV-infected individuals including HAR and LAR (Fig  2. Basal) . However, it is important to keep in mind that the method we used is unable to determine if thiol replenishment results as a consequence of enhanced intracellular GSH, cystein, or SH containing NAC. In addition, cysteine accumulation rather than GSH after NAC replenishment, could result from impaired g-glutamyl-cysteinesynthetase, which cannot be excluded to occur in lymphocytes from HIV-infected individuals. These results indicate that the different susceptibility of high and low responder groups of patients to recover impaired proliferative responses, is not dependent on restoration of basal lymphocyte thiol levels. However, when compared with normals and HAR, cells from LAR failed to maintain adequate intracellular thiol levels (Fig 2) after overnight cultures irrespectively of antioxidant treatment or CD3-mediated activation (more than twofold reduction). These results suggest that inability of antioxidant treatment to restore in vitro proliferative responses in CD4 T cells from LAR could be the consequence of an impairment in cellular mechanisms aimed to maintain adequate intracellular thiol levels needed for normal cellular physiology. However, the possibility of an in vivo-triggered process unrelated to redox status cannot be excluded.
Antioxidant treatment restored the proliferative responses of unresponsive CD4' T cells hut failed to affect cells undergoing PCD. PCD has been proposed to play an important role in CD4 depletion during HIV infe~tion'~-*~ and there is growing evidence indicating that oxidative stress may be involved in this proce~s.'?.".'~ Thus, we have speculated that in vitro-enhanced proliferative responses to antioxidant preincubation in a fraction of HIV-infected individuals could be the consequence of PCD inhibition.The ratio of apoptotic cells was evaluated by fluorescence-activated cell sorting (FACS) using the merocyanine 540 fluorescent probe which The percentage of apoptotic cells was, respectively, 5%, 7%, 8%, 25%, and 13% before stimulation and 16%. 17%, 19%, 66%, and 32% after 24 hours in culture. Because results were similar in the presence or the absence of NAC + 2-ME or in the absence or presence of anti-CD3 stimulation, these results correspond to those obtained in the presence of NAC + 2-ME and in the absence of CD3 stimulation. Figure   3 depicts the differences between extreme cases in the HAR and LAR groups. Although HIV-09 patients may represent an extreme case, because in our hands it is unusual to find 25% of cells in spontaneous apoptosis, it clearly shows that the inability to display proliferative response may result from the high number of dead cells to incorporate thymidine. On the contrary, in patients from the HAR group, cell death was not significantly different from normals (< l5%), at least during the first 24 hours of culture (Fig 3) . Of note, in contrast to Gougeon and Montagnie?' and Groux et who reported an increased activation-induced cell death following superantigen, calcium ionophore and soluble CD3 stimulation, in the experimental conditions used in this work, CD3-mediated stimulation of purified CD4 T cells was not associated with enhanced cell death, but with a moderate decrease in the fraction of merocyanin high (apoptotic) cells when compared with nonactivated cells. These apparently opposed results are probably accounted by differences in experimental conditions, since in a previous work we failed to substantiate increase in activation-induced cell death after stimulation with immobilized CD3 of purified CD4 T Moreover, as in our experimental conditions we are unable to induce activation-mediated cell death, we cannot exclude the possibility that NAC treatment could have an effect in inhibition of this phenomenon. Taken together, these results showed that antioxidant treatment was able to restore proliferative responses in a high proportion of asymptomatic HIVinfected individuals, without a significant effect on the ratio of apoptotic cells. Indeed, recovery of the proliferative responses by antioxidant treatment was not mediated by inhibition of PCD, but rather by recovery of the impaired proliferative ability of nonapoptotic lymphocytes. However, taking into account that our work was performed with isolated CD4 cells, which may not correspond to "in vivo"-like conditions, they need to be further evaluated. On the contrary, in HIV-infected patients with a high ratio of apoptotic CD4' lymphocytes, in vitro antioxidant treatment was not able to inhibit cell death and, therefore, not able to significantly influence proliferative responses.
DISCUSSION
Because recent reports suggested that oxidative stress and GSH depletion may play an important role in HIV-induced immunopathogene~is,~'" we speculated that an imbalance in the cellular redox status might account, at least partially, for impaired proliferative responses of CD4' lymphocytes from HIV-infected individuals.' In agreement with these reports, we have observed decreased levels of intracellular low molecular thiols in resting CD4' T cells from asymptomatic HIV-infected individuals, suggesting the possibility of an in vivo oxidative stress. In this respect, recent reports demonstrated that T lymphocytes from HIV-infected patients were characterized by a substantial decrease in reduced glutathion, in the ratio of reduced to total glutathion and a considerable increase in oxidized glutathion."'"
To assess the effects of replenishing cellular thiol contents on impaired proliferative responses, cells were preincubated with the thiol-containing antioxidant NAC plus 2-ME. In our experimental conditions, CD4' lymphocytes from a majority of asymptomatic HIV-infected individuals (8 of l I ) restored impaired proliferative responses to a level close to that observed in normal controls under the same experimen- tal conditions. Although several research groups have shown that antioxidants used in vitro can inhibit HIV transcription by suppressing activation of the transcription factor NFkB,""* there are contradictory results concerning the effect of these molecules on normal lymphocyte proliferation and function.
Several groups indicated that a series of free-radical scavengers, including NAC and 2-ME, are able to inhibit proliferation, IL-2 secretion, and induction of the IL-2 receptor initiated by alloantigens or mitogens in murine and human T cell~."'~'' On the other hand, several reports have dealt with the enhancement of T-cell and PBMC proliferative activity upon antioxidant treatment, which directly or indirectly enhances the intracellular contents of thiols.'"." In addition, recent work indicates that the capacity of PBMC to enter the cell cycle correlates with intracellular GSH contentsT4 and that the generation of reactive oxygen intermediates (ROI) at the membrane level is essential in mitogen-and antigen-induced lymphocyte activation and their associated signaling.3s,36 TCR stimulation of T lymphocytes through increased production of ROI, as well as acute in vitro exposure to oxidants, induces tyrosine-kinase activation and/or tyrosine-phosphatase inhibition, resulting in an increased tyrosine-phosphorylation of these cells.37 In agreement with these reports, resulting in an increased tyrosine phosphorylation of these cells,"-3x Staal et al" have shown that a moderate decrease in GSH levels is able to impair Ca" influx and proliferative responses in anti-CD3 stimulated T cells, which could be mediated by increased phosphorylation of inhibitory sites of Lck and fyn. Flescher et a13y have recently reported that chronic low-level oxidative stress results in suppression of protein-tyrosine phosphorylation and calcium mobilization. These results could explain our previous findings of defective protein-tyrosine phosphorylation in CD4 lymphocytes from HIV patients." Therefore, chronic LMT depletion in HIV infection could determine a defective tyrosine-phosphorylation response through increased production For personal use only. on October 22, 2017. by guest www.bloodjournal.org From of ROI, as well as acute in vitro exposure to oxidants induces increased tyrosine phosphorylation andor tyrosine-phosphatase inhibition, resulting in an increased tyrosine phosphorylation of these ~e l l s ?~-~~ Indeed, GSH depletion has significantly detrimental effects in normal lymphocyte function, perhaps by causing change in the activity of vital enzymes required for cellular metabolism, DNA synthesis, and signal transduction. Additionally, GSH has an essential role in protecting cell against ROI generation. However, to define the precise mechanism accounting for the effect of antioxidant treatment, a detailed study of signal transduction pathways, assessment of the respective role of the different thiols, as well as the different metabolic pathways involved in redox regulation, is needed. Because progression into the cell cycle may depend on the levels of intracellular GSH capable of restoring the activation-induced redox i m b a l a n~e ,~~.~~ it can be assumed that the presence of antioxidants during the activation process may inhibit the generation of ROI that are postulated to play an essential role in lymphocyte ~ignaling.~' Because in our work subsequent activation proceeded in the absence of antioxidants, this resulted in significant enhancement of the proliferative activity of CD4 T cells from both normal and HIV-infected individuals. This apparent discrepancy can be explained by our results (Fig I) , indicating that when activation was performed in the presence of NAC, there was a dose-dependent inhibition of lymphocyte proliferation, whereas preincubation with NAC followed by washing of supernatants and subsequent stimulation determined opposite results. Furthermore, similar conclusions were reported by Aillet et Our results are in agreement with the idea that the capacity of PBMC to enter the cell cycle correlates with intracellular GSH contents34 and that the generation of ROI at the membrane level is essential in mitogen and antigen-induced lymphocyte activation and their associated sigr~aiing."'~~ Because progression into the cell cycle may depend on the levels of intracellular GSH capable of restoring the activation-induced redox imbalan~e,~'"~ it can be assumed that the presence of antioxidants during the activation process may inhibit the generation of ROI, which are postulated to play an essential role in lymphocyte signaling. 35 As depicted in Tables 1 and 2 , there was only a rough correlation between individual thiol levels and the severity of impairment in the respective proliferative responses for HIV-infected individuals. In this respect, it is known that cellular GSH levels are submitted to a tight regulation by an enzyme-regulated precise redox equilibrium and thereby the actual low-molecular thiol levels could not reflect the state of protein sulfhydryls. Alternatively, because lymphocyte activation is dependent on adequate levels of GSH to use it in a variety of reactions, including synthesis of proteins and DNA precursors, we speculated on the possibility of a deficient recycling of cellular thiols after their activationinduced consumption. In this regard, it has been proposed that HIV-infected lymphocytes display deficient activity of enzymes acting as scavengers of reactive oxygen intermediates (ROI) generated during lymphocyte activation as superoxide dismutase (SOD), catalase, glutathion reductase, and thioredoxine.26 When thiol levels were determined after overnight in in vitro cultures (activated and nonactivated lymphocytes), we observed that CD4+ lymphocytes from the LAR responders group failed to maintain adequate levels of intracellular thiols (Fig 2) , irrespective of antioxidant treatment or CD3-mediated activation. Data presented in this figure suggest an impairment in the cellular antioxidant machinery aimed to maintain an appropiate redox status in CD4 T cells from HIV-infected patients who are unresponsive to antioxidant treatment. In contrast, in the HAR group despite reduced basal cellular thiols, the replenishment of intracellular thiols resulted in restoration of functional responses, indicating that antioxidant defenses are adequated.
PCD has been proposed to play an important role in CD4+ lymphocyte depletion during HIV i n f e c t i~n ,~~-~~ and oxidative stress might be involved in this process.1Z.'3.Z6 We speculated on the possibility that impaired proliferative responses in CD4' lymphocytes from the LAR could result from an abnormally triggered PCD process. Data presented in Fig 3 showed that recovery of proliferative responses in CD4' lymphocytes from HIV-infected individuals was dependent on the ratio of apoptotic cells, indicating that enhancement of proliferative responses induced by NAC + 2-ME was limited to nonapoptotic cells. Although we did not assess the percentage of apoptotic cells previous to the measurement of thymidine uptake, the number of apoptotic cells observed before culture and 24 hours after culture for five patients indicates that there is a straightforward correlation between apoptosis and results of thymidine incorporation. These results show that the NAC-mediated increase in proliferative responses was not associated with apoptosis inhibition, but with enhanced proliferative ability of ''nonapoptotic cells" or anergic cells and that the absence of proliferative response enhancement and the inability to maintain adequate LMT levels in vitro may probably be accounted by the fact that cells are dying in cultures.
An inhibitory effect of NAC on lymphocyte apoptosis was recently demonstrated in the case of apoptosis induced by TNF-a and phorbol esters in a chronically HIV-infected monomyelocytic cell line.I3 This effect was proposed to be mediated via GSH replenishment by NAC treatment. Similarly, it has been reported that NAC could inhibit activationinduced DNA fragmentation in T lymphocytes as a consequence of changes in intracellular redox s t a t~s .~~~~' Thus, the possibility exists that the concentration of NAC or the duration of treatment in our experimental conditions may be insufficient to inhibit cell death. Because mechanisms other than oxidant-induced cell death cannot be excluded, an alternative hypothesis could be that in vitro cell death in these patients results from an irreversible process triggered in vivo, which may not be influenced by in vitro antioxidant treatment. NAC has been reported to have beneficial effects on CD4 lymphocyte survival when administrated to HIV-1 -infected individuals." However, it is presently unclear whether the reasons for these contradictory results depend on differences in experimental conditions (cells and apoptosis inductors, in vivo v in vitro conditions). In agreement with this, a recent report shows that NAC may have variable and even opposite effects on DNA fragmentation depending on inductors and cell type tested!' Thus, the induction of For personal use only. on October 22, 2017. by guest www.bloodjournal.org From apoptosis in T cells is a complex and multifactorial process that probably involves several different signaling pathways.
Overall, these results show for the first time that antioxidant treatment is able to revert, at least in some cases, the impaired proliferative activity of CD4 cells from HIV-infected patients. However, this action was mainly occurring on unresponsive cells, but not on cells engaged in ongoing programmed cell death, although it remains unclear whether this effect could be exerted at very initial stages of this process. Taking into account the important role of intracellular low-molecular thiols in proliferative responses and in protection of T cells from oxidative damage, our data suggest that a redox imbalance may be involved in the CD4 proliferative defect observed in HIV-1 patients. Thus, the results reported here, together with others indicating that NAC is a potent inhibitor of HIV replication, may help designing therapeutic strategies with antioxidant drugs in HIV disease.
